Modified AXL Peptides and Their Use in Inhibition of AXL Signaling in Anti-Metastatic Therapy
US-2022220458-A1 · Jul 14, 2022 · US
Aravive Biologics Inc holds 7 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 7 |
| Recent patents | 0 |
| First publication | Nov 21, 2017 |
| Latest publication | Jul 14, 2022 |
Year-over-year patent counts for this assignee.
Latest publications where this party is an assignee.
US-2022220458-A1 · Jul 14, 2022 · US
US-11136563-B2 · Oct 5, 2021 · US
US-10876176-B2 · Dec 29, 2020 · US
US-2018094034-A1 · Apr 5, 2018 · US
US-2018030422-A1 · Feb 1, 2018 · US
Representative or frequently cited publications from precomputed assignee stats.
US-2022220458-A1 · Jul 14, 2022 · US
US-11136563-B2 · Oct 5, 2021 · US
US-10876176-B2 · Dec 29, 2020 · US
US-2018094034-A1 · Apr 5, 2018 · US
US-2018030422-A1 · Feb 1, 2018 · US
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Human Necessities | 7 |
| Chemistry & Metallurgy | 7 |
| Physics | 2 |
Answers are generated from the same data shown on this page.